Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cyclerion Therapeutics (CYCN) Asset Utilization Ratio (2019 - 2025)

Cyclerion Therapeutics (CYCN) has disclosed Asset Utilization Ratio for 7 consecutive years, with 0.29 as the latest value for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 1310.51% year-over-year to 0.29; the TTM value through Sep 2025 reached 0.29, up 1310.51%, while the annual FY2024 figure was 0.17, N/A changed from the prior year.
  • Asset Utilization Ratio hit 0.29 in Q3 2025 for Cyclerion Therapeutics, up from 0.23 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.29 in Q3 2025 and bottomed at 0.01 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.1, with a median of 0.05 recorded in 2021.
  • Year-over-year, Asset Utilization Ratio crashed 76.12% in 2023 and then soared 1310.51% in 2025.
  • Cyclerion Therapeutics' Asset Utilization Ratio stood at 0.06 in 2021, then fell by 24.01% to 0.05 in 2022, then crashed by 56.06% to 0.02 in 2023, then soared by 944.98% to 0.22 in 2024, then skyrocketed by 33.28% to 0.29 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.29, 0.23, and 0.21 for Q3 2025, Q2 2025, and Q1 2025 respectively.